Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)

Yifeng Pharmacy Chain Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,305	3,579	3,566	4,113	2,921	3,360
Short-Term Investments	-	-	-	-	-	4
Trading Asset Securities	4,446	4,407	1,631	50.05	152.19	744.84
Cash & Short-Term Investments	7,751	7,986	5,197	4,163	3,073	4,109
Cash Growth	5.61%	53.67%	24.84%	35.46%	-25.22%	146.78%
Accounts Receivable	1,657	2,153	2,150	1,846	1,087	831.17
Other Receivables	369.25	477.94	448.54	419.47	323.6	207.6
Receivables	2,027	2,631	2,599	2,265	1,411	1,039
Inventory	4,235	4,528	3,808	3,615	3,041	2,172
Prepaid Expenses	-	-	-	-	35.17	-
Other Current Assets	686.92	710.58	525.62	535.91	356.71	341.71
Total Current Assets	14,700	15,856	12,129	10,578	7,916	7,662
Property, Plant & Equipment	5,260	5,679	5,665	4,892	4,504	3,550
Long-Term Investments	515.17	530.22	592.97	334.09	6.72	6.72
Goodwill	4,772	4,769	4,611	4,188	3,718	3,338
Other Intangible Assets	467.1	483.09	470.97	478.2	389.25	370.68
Long-Term Deferred Tax Assets	141.68	148.62	138.67	127.68	109.79	74.15
Long-Term Deferred Charges	454.68	493.88	499.14	430.69	379.59	267.45
Other Long-Term Assets	8.26	15.17	30.27	7.23	28.39	58.37
Total Assets	26,318	27,975	24,137	21,036	17,052	15,327
Accounts Payable	8,038	9,492	8,171	6,761	4,806	3,822
Accrued Expenses	441.92	587.26	549.68	683.11	390	332.21
Short-Term Debt	30.03	30.03	-	-	-	380.32
Current Portion of Long-Term Debt	2.93	66	103.48	92.92	4.21	58.9
Current Portion of Leases	1,141	1,271	1,355	1,185	931.44	748.43
Current Income Taxes Payable	192.53	207.1	165.76	176.87	148.83	78.14
Current Unearned Revenue	171.05	130.07	80.17	60.69	41.1	30.54
Other Current Liabilities	622.04	814.24	844.45	700.13	424.11	416.39
Total Current Liabilities	10,640	12,598	11,269	9,659	6,745	5,867
Long-Term Debt	1,626	1,601	133.62	228.67	365.65	1,976
Long-Term Leases	2,100	2,313	2,206	1,951	2,024	1,766
Long-Term Unearned Revenue	53.41	53.63	54.09	54.69	50.34	51.46
Long-Term Deferred Tax Liabilities	13.38	15.41	26.76	23.71	2.16	2.41
Total Liabilities	14,433	16,581	13,689	11,917	9,187	9,664
Common Stock	1,212	1,212	1,011	721.7	718.77	531.52
Additional Paid-In Capital	3,545	3,545	3,716	3,991	3,988	2,594
Retained Earnings	6,088	5,693	4,973	3,849	2,802	2,080
Treasury Stock	-3.51	-3.76	-42.24	-77.41	-27.76	-63.02
Comprehensive Income & Other	312.12	278.95	147.93	68.34	-	215.67
Total Common Equity	11,154	10,726	9,804	8,553	7,481	5,359
Minority Interest	731.2	667.88	642.66	565.39	383.24	304.81
Shareholders' Equity	11,885	11,394	10,447	9,119	7,865	5,663
Total Liabilities & Equity	26,318	27,975	24,137	21,036	17,052	15,327
Total Debt	4,901	5,281	3,798	3,458	3,325	4,930
Net Cash (Debt)	2,850	2,705	1,399	705.02	-252.57	-821.45
Net Cash Growth	65.95%	93.32%	98.44%	-	-	-
Net Cash Per Share	2.28	2.19	1.16	0.58	-0.21	-0.71
Filing Date Shares Outstanding	1,212	1,212	1,213	1,212	1,208	1,208
Total Common Shares Outstanding	1,212	1,212	1,213	1,212	1,208	1,161
Working Capital	4,060	3,258	859.44	918.95	1,171	1,795
Book Value Per Share	9.20	8.85	8.08	7.05	6.20	4.62
Tangible Book Value	5,915	5,474	4,723	3,887	3,374	1,650
Tangible Book Value Per Share	4.88	4.51	3.89	3.21	2.79	1.42
Buildings	1,375	1,364	1,291	1,004	683.76	415.71
Machinery	1,193	1,174	1,001	843.34	722.34	546.17
Construction In Progress	251.66	228.58	175.12	239.85	358.64	235.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.